Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015)

Enanta Pharmaceuticals' (ENTA) quarterly Minority Interest came in at $164000.0 in Q4 2015, up 0.61% on a QoQ basis from $163000.0 in Q3 2015.

Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015) Analysis & Trends

Enanta Pharmaceuticals (ENTA) has 2 years of Minority Interest data on file, last reported at $164000.0 in Q4 2015.

Quarterly Minority Interest changed N/A year-over-year to $164000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $164000.0 (changed N/A YoY) and the FY2015 annual result came in at $163000.0, down 19.31% from the prior year.
Minority Interest grew to $164000.0 in Q4 2015, from $163000.0 in the prior quarter.
In the past five years, Minority Interest ranged from a high of $202000.0 in Q3 2014 to a low of $163000.0 in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Enanta Pharmaceuticals	383.29 Mn	193.78 Mn	-

Download Data